Inhibitors of farnesylation of Ras from a microbial natural products screening program.
Mutant ras oncogenes are associated with various human tumors such as pancreas, colon, lung, thyroid, bladder and several types of leukemia. Prenylation of Ras proteins plays a major role in cell proliferation of both normal and cancerous cells. Normal and oncogenic Ras proteins are posttranslationally modified by a farnesyl group that promotes membrane binding. Inhibitors of farnesyl protein transferase (FPTase), the enzyme that catalyzes the prenylation of Ras proteins, inhibit growth of tumor cells. In an effort to identify structurally diverse and unique inhibitors of FPTase, a program devoted to screening of natural products was initiated. This effort led to the identification of 10 different families of compounds, all of which selectively inhibit FPTase with a variety of mechanisms that are reviewed in this manuscript. These compounds originated from the fermentations of a number of microorganisms, either actinomycetes or fungi, isolated from different substrates collected in tropical and temperate areas. A chemotaxonomic discussion on the distribution of each compound among single or different types of microorganisms, either phylogenetically related or unrelated species, is included.
Vilella
D
D
Centro de Investigación Básica, Natural Products Drug Discovery, Merck Sharp and Dohme de España, S.A. Josefa Valcárcel 38, 28027 Madrid, Spain.
Sánchez
M
M
Platas
G
G
Salazar
O
O
Genilloud
O
O
Royo
I
I
Cascales
C
C
Martín
I
I
Díez
T
T
Silverman
K C
KC
Lingham
R B
RB
Singh
S B
SB
Jayasuriya
H
H
Peláez
F
F